Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
PCRX
#2109
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-5.88%
Monatliche Änderung
+10.54%
6 month change
+0.37%
Jahresänderung
+0.37%
Vorheriger Schlusskurs
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volumen
171
Märkte
Aktien
Gesundheitswesen
PCRX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.86 M
44.85 M
45.95 M
46.5 M
46.28 M
40.49 M
—
Valuation ratios
Enterprise value
2.52 B
2.11 B
1.68 B
1.33 B
595.07 M
889.33 M
3.49 B
Price to earnings ratio
17.97
65.4
114.29
35.96
-8.76
161.75
194.53
Price to sales ratio
6.08
5.07
2.71
2.46
119.65
—
—
Price to cash flow ratio
33.93
21.84
12.45
10.76
4.6
7.67
30.88
Price to book ratio
4.22
3.76
2.33
1.91
1.12
1.68
2.79
Enterprise value to EBITDA ratio
8.64
6.03
4.07
2.8
-1.67
—
—
Profitability ratios
Return on assets %
0.11
0.02
0.01
0.03
-0.06
0.01
-0.01
Return on equity %
0.23
0.06
0.02
0.05
-0.13
0.01
-0.02
Return on invested capital %
-155.42
22.44
13.41
19.05
-11.09
3.31
0.87
Gross margin %
72.69
74.1
70.11
72.64
-2 240.4
79.39
317.56
Operating margin %
10.79
16.61
9
12.99
-1 007.57
2.64
10.6
EBITDA margin %
68.05
64.67
61.97
70.6
-4 903.28
13.36
23.17
Net margin %
33.87
7.75
2.39
6.22
-1 367.21
0.97
-6.26
Liquidity ratios
Quick ratio
2.32
1.47
2.72
4.17
2
3.28
10.96
Current ratio
2.57
1.66
3.37
5.24
2.4
4.54
14.6
Inventory turnover
—
—
—
—
—
0.01
—
Asset turnover
0.41
0.32
0.36
0.41
0
0.52
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.33
0.39
0.33
0.25
0.29
1.07
Long term debt to total equity ratio
0.51
0.92
0.85
0.59
0.49
0.54
2.03
Per share metrics
Operating cash flow per share
1.76
2.76
3.12
2.98
4.1
3.37
3.32
EBIT per share
6.24
7.05
6.91
7.71
-9.42
0.13
-1.24
EBITDA per share
6.69
7.68
8.88
9.17
-7.72
2.15
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.94
14.39
6.2
5.36
10.48
5.29
31.01
Net current asset value per share
14.92
18.98
10.71
9.81
16.11
12.17
57.06
Tangible book value per share
9.7
-0.85
1.53
4.3
7.62
6.77
28.08
Working capital per share
9.12
7.56
7.53
7.94
9.41
9.49
38.45
Book value per share
14.19
16.01
16.65
16.74
16.83
15.39
64.98
Nachrichten
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Pacira vor Quartalszahlen: Generika-Bedrohung für EXPAREL im Fokus
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
Insider-Verkauf bei Pacira BioSciences: Finanz-SVP verkauft Aktien im Wert von 83.000 $
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Pacira BioSciences: Führungskraft verkauft Aktien im Wert von rund 270.000 US-Dollar
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Pacira BioSciences appoints Samit Hirawat to board of directors
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why
Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?